The nizatidine market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2031.
United States Nizatidine Market is Expected to Grow at a 7.2% CAGR by 2031
The nizatidine market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2031. The survey offers nizatidine demand outlook and studies opportunities existing in key segments, including type and distribution channel. It also highlights key strategies adopted by market players to increase nizatidine sales.
Fact.MR - A Market Research and Competitive Intelligence Provider: Rising prevalence of gastrointestinal problems such as inflammatory bowel disease (IBD), constipation, hemorrhoids, and stomach ulcers has resulted the global nizatidine market in showing favorable growth. According to a study conducted by Fact.MR, the nizatidine market is expected to grow at a CAGR of over 9% from 2021 to 2031.
According to the British Medical Association (BMA), non-communicable diseases (NCDs) account for more than 60% of all diseases worldwide, with stomach disorders accounting for the majority of this burden.
Get a Sample Copy With Impact Analysis Of COVID-19 Of Market Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=6217
Over 60 million people are suffering from various digestive ailments, resulting in the hospitalization of more than 1 million in the U.S., according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). As nizatidine has proven as an effective compound for the cure of gastric problems, the demand for nizatidine is estimated to surge.
Several organizations are launching campaigns to raise awareness of stomach issues. For example, in the United States, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is actively financing several research initiatives aimed at analyzing the complicated interplay of environmental, microbial, and immunological components that contribute to gastric illnesses. The market for nizatidine is expected to grow as a result of such activities.
Furthermore, Due to its anti-inflammatory properties, nizatidine is being studied in the hopes of developing anti-viral drugs that could be extremely helpful in combating the COVID-19 pandemic.
“The market players are increasingly investing in developing new drugs and focusing on obtaining regulatory approvals from prominent authorities to cater to the increasing demand for nizatidine,” says the Fact.MR analyst.
Key Takeaways
- Due to steps implemented by leading organizations to curb gastrointestinal disorders, the United States is expected to be the largest nizatidine market in North America over the projection period.
- As the world's largest provider of generic pharmaceuticals, India's market for nizatidine is predicted to rise threefold by 2031.
- Due to the increasing frequency of gastrointestinal problems in China, it is likely to become a lucrative industry.
- Nizatidine capsule is the most popular product in the segment, with sales rising at a CAGR of more than 10% during the projection period.
- As the major point of distribution, hospital pharmacies have the biggest market share.
Key Drivers
- As the incidence of gastrointestinal problems rises, so will the demand for nizatidine.
- The market will develop as more programs to raise awareness about gastrointestinal problems are implemented.
- Gastric issues have been noted among COVID-19 patients. The COVID-19 outbreak will increase demand for nizatidine.
- Increasing medical infrastructure investment is likely to boost market growth in developing economies.
Key Restraints
- Negative side effects of the medications, such as constipation, diarrhea, headache, and others, will reduce demand for nizatidine.
- The rise of nizatidine is being hampered by voluntary medicine recalls by regulatory organizations.
- The availability of nizatidine substitutes may limit market expansion.
To gain in-depth insights on Nizatidine Market, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6217
Competitive Landscape
To promote their products, prominent nizatidine manufacturers rely on regulatory sanctions from competent authorities, as well as methods such as mergers, acquisitions, and collaborations.
- Glenmark Pharmaceuticals, one of the leading Indian manufacturer, offers wide range of Nizatidine Oral Capsules including dosages of 300 milligrams, manufactured for treating active duodenal ulcers.
- MedChemExpress, manufactures nizatidine for treating intestine and stomach ulcers. It enhance in secretion of gastric acid, resulting in preventing ulcer recurrence.
Prominent players operating in the Nizatidine market are:
- Flynn Pharma
- MedChemExpress
- Mylan N.V.
- Glenmark Pharmaceuticals
- Weightech (Hunan) Pharmaceutical
- Hengdian Group
- Dr. Reddy’s Laboratories
- Eli Lily and Company
- Strides Pharma Science Limited
More Valuable Insights on Nizatidine Market
Fact.MR, in its new report, offers an unbiased analysis of the global nizatidine market, analyzing forecast statistics through 2021 and beyond. The study reveals growth projections on nizatidine market with detailed segmentation:
- Type
- Nizatidine Capsules
- Nizatidine Tablets
- Other Nizatidine Types
- Distribution Channel
- Nizatidine for Hospital Pharmacies
- Nizatidine for Retail Pharmacies
- Nizatidine for Online Pharmacies
Explore Fact.MR’s Coverage on the Healthcare Domain –
Peptide Based Gastrointestinal Disorders Therapeutics Market Scope - Peptides are projected to become more widely used in various therapeutic fields in the near future. The development of more effective peptide-based therapeutic medications for treating gastrointestinal problems is likely to be aided by technological advancements in peptide synthesis.
Rhizoma Gastrodiae Tablets Market Insights - Traditional herbal medicines are acquiring significant attention in the global healthcare industry. Traditional herbal medicine is likely to make substantial progress in the worldwide market, with nations such as China, India, Nigeria, and the United States expected to lead the way, boosting the prospects for rhizoma gastrodiae tablets.
Antibiotic-Associated Diarrhea Treatment Market Analysis - The market for antibiotic-associated diarrhea treatment has grown as a result of the availability of over-the-counter medications, which has contributed to an increase in the prevalence of antibiotic-associated diarrhea.
Drug Discovery Services Market Forecast - The expansion of drug discovery services can be attributed to an increase in research and development efforts and expenditures, as well as leading pharmaceutical companies' shift to outsourcing. The use of improved technology in the drug discovery process is also a major market growth factor.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to chemical and materials, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our chemical and materials research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR